The next big target for vaccine makers including Pfizer, Moderna and J&J is RSV, one of the last remaining childhood diseases without an approved shot
Children under 5 in the U.S. aren’t yet eligible for a Covid-19 vaccine after efforts to get the shots to market have hit setbacks. WSJ’s Peter Loftus explains what we know about the vaccines and when they might become available.
Photo composite: Todd JohnsonAfter Covid-19, vaccine makers’ next big target is a respiratory virus that kills up to 500 children a year nationwide and has been among the leading causes of U.S. hospitalizations for decades., infects nearly everyone at some point, causing mild, cold-like symptoms for most people. But it can lead to serious health problems such as difficulty breathing and pneumonia for infants and older adults.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Covid booster shot bolsters protection in 5-to-11-year-olds, Pfizer and BioNTech sayThe third shot appears to broaden the ability of the immune system to recognize variants such as omicron.
Leer más »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNow Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot.
Leer más »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy children ages 5-11.
Leer más »
Pfizer to seek COVID-19 booster for healthy 5- to 11-year-oldsPfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Leer más »
Pfizer aims to expand COVID booster shot to healthy kids ages 5 to 11Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized COVID-19 shot.
Leer más »
Pfizer to seek COVID booster for healthy 5- to 11-year-oldsNEW: Pfizer says it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Leer más »